Public Policy Committee

The ASAM Public Policy Committee (PPC) is responsible for overseeing the development of ASAM Policy Statements and joint policy statements with allied organizations. It also considers and recommends endorsement of non-ASAM (external) policy statements.

ASAM Public Policy Statements are statements of ASAM’s positions and recommendations regarding addiction‐related issues, clinical care, and health policy.


Jeff Selzer, MD, FASAM

Randolph Holmes, MD, FASAM


  • Aleksandra Zgierska, MD, PhD, DFASAM
  • Anna Lembke, MD, FASAM
  • David Smith, MD, DFASAM
  • Elizabeth Salisbury-Afshar, MD, MPH, FASAM
  • Howard Wetsman, MD, DFASAM
  • Jim Harrow, MD, PhD, FASAM
  • Ken Roy, MD, DFASAM
  • Mark Kraus, MD, DFASAM
  • Mark Jameson, MD, FASAM 
  • Michael Miller, MD, DFASAM
  • Mishka Terplan, MD, MPH, FASAM
  • Norm Wetterau, MD, DFASAM
  • Robert DuPont, MD,DFASAM
  • Robert Levy, MD, FASAM
  • Sharon Stancliff, MD, FASAM
  • William Haning, MD, DFASAM
  • Yngvild Olsen, MD, MPH, DFASAM

Staff Liaisons:

  • Kelly Corredor, Director, Advocacy & Government Relations, ASAM
  • Connor Galvin, Specialist, Federal Advocacy & Policy, ASAM